175 related articles for article (PubMed ID: 30573046)
1. The challenging task of enumerating blasts in the bone marrow.
Hodes A; Calvo KR; Dulau A; Maric I; Sun J; Braylan R
Semin Hematol; 2019 Jan; 56(1):58-64. PubMed ID: 30573046
[TBL] [Abstract][Full Text] [Related]
2. Blast counts are lower in the aspirate as compared to trephine biopsy in acute myeloid leukemia and myelodysplastic syndrome expressing CD56.
Drexler B; Tzankov A; Martinez M; Baerlocher S; Passweg JR; Dirnhofer S; Tsakiris DA; Dirks J
Int J Lab Hematol; 2021 Oct; 43(5):1078-1084. PubMed ID: 33709561
[TBL] [Abstract][Full Text] [Related]
3. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
4. CD34/QBEND10 immunostaining in the bone marrow trephine biopsy: a study of CD34-positive mononuclear cells and megakaryocytes.
Torlakovic G; Langholm R; Torlakovic E
Arch Pathol Lab Med; 2002 Jul; 126(7):823-8. PubMed ID: 12088452
[TBL] [Abstract][Full Text] [Related]
5. Normalization of bone marrow aspirates for hemodilution in flow cytometric analyses.
Loken MR; Chu SC; Fritschle W; Kalnoski M; Wells DA
Cytometry B Clin Cytom; 2009 Jan; 76(1):27-36. PubMed ID: 18548614
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of blast percentage assessed by bone marrow trephine biopsy and aspirate smear of myeloid malignancies.
Yang CF; Gau JP; Hsiao LT; Hsu CY
Pathology; 2021 Oct; 53(6):740-745. PubMed ID: 33745704
[TBL] [Abstract][Full Text] [Related]
7. CD34 immunohistochemistry in bone marrow biopsies for early response assessment in acute myeloid leukemia.
Jain S; Mahapatra M; Pati HP
Int J Lab Hematol; 2015 Dec; 37(6):746-51. PubMed ID: 26248894
[TBL] [Abstract][Full Text] [Related]
8. Myelopoiesis and myeloproliferative disorders.
Raskin RE
Vet Clin North Am Small Anim Pract; 1996 Sep; 26(5):1023-42. PubMed ID: 8863389
[TBL] [Abstract][Full Text] [Related]
9. [Pattern analytic investigations of blast cells in myelodysplastic syndrome and secondary acute myeloid leukemia].
Baumann I; Harms H; Kuse R; Feller AC; Müller-Hermelink HK
Verh Dtsch Ges Pathol; 1990; 74():135-8. PubMed ID: 1708571
[TBL] [Abstract][Full Text] [Related]
10. Histopathology of myelodysplastic syndromes. The FAB classification (proposals) applied to bone marrow biopsy.
Delacrétaz F; Schmidt PM; Piguet D; Bachmann F; Costa J
Am J Clin Pathol; 1987 Feb; 87(2):180-6. PubMed ID: 3812349
[TBL] [Abstract][Full Text] [Related]
11. CD34 immunohistochemical staining of bone marrow biopsies in myelodysplastic syndromes.
Min YH; Lee ST; Min DW; Kim TS; Lee CH; Lee BK; Hahn JS; Ko YW
Yonsei Med J; 1995 Mar; 36(1):1-8. PubMed ID: 7537931
[TBL] [Abstract][Full Text] [Related]
12. Prognostic relevance of the flow cytometric count of medullar blasts in myelodysplastic syndromes.
Molteni A; Riva M; Cesana C; Speziale V; Nichelatti M; Scarpati B; Greco R; Ravano E; Cairoli R; Rossini S; Morra E
Eur J Haematol; 2015 Jun; 94(6):519-25. PubMed ID: 25307971
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of blast cell counts in dysplastic bone marrow disorders (MDS and CMML I) with concomitant fibrosis.
Machherndl-Spandl S; Sega W; Bösmüller H; Germing U; Gruber Ch; Nachtkamp K; Reinecke P; Sperr WR; Wimazal F; Müllauer L; Sotlar K; Horny HP; Tüchler H; Valent P; Krieger O
Ann Hematol; 2014 Jan; 93(1):57-64. PubMed ID: 24241126
[TBL] [Abstract][Full Text] [Related]
14. Combined flow cytometric assessment of CD45, HLA-DR, CD34, and CD117 expression is a useful approach for reliable quantification of blast cells in myelodysplastic syndromes.
Sandes AF; Kerbauy DM; Matarraz S; Chauffaille Mde L; López A; Orfao A; Yamamoto M
Cytometry B Clin Cytom; 2013 May; 84(3):157-66. PubMed ID: 23475532
[TBL] [Abstract][Full Text] [Related]
15. Myelodysplastic syndromes, chronic myeloproliferative diseases, and myelodysplastic/myeloproliferative diseases.
Vardiman JW
Semin Diagn Pathol; 2003 Aug; 20(3):154-79. PubMed ID: 14552429
[TBL] [Abstract][Full Text] [Related]
16. [Histopathologic diagnosis of bone marrow in leukemia and related disorders].
Kikuchi M; Ohshima K; Kobari S
Rinsho Byori; 1991 Dec; 39(12):1245-9. PubMed ID: 1779461
[TBL] [Abstract][Full Text] [Related]
17. Automated digital enumeration of plasma cells in bone marrow trephine biopsies of multiple myeloma.
Malherbe JAJ; Fuller KA; Mirzai B; Augustson BM; Erber WN
J Clin Pathol; 2022 Jan; 75(1):50-57. PubMed ID: 33234694
[TBL] [Abstract][Full Text] [Related]
18. QBEND10 for the diagnosis of myelodysplastic syndromes in routinely processed bone marrow biopsy specimens.
Horny HP; Wehrmann M; Schlicker HU; Eichstaedt A; Clemens MR; Kaiserling E
J Clin Pathol; 1995 Apr; 48(4):291-4. PubMed ID: 7542289
[TBL] [Abstract][Full Text] [Related]
19. Identification of CD34+ cells in normal and pathological bone marrow biopsies by QBEND10 monoclonal antibody.
Soligo D; Delia D; Oriani A; Cattoretti G; Orazi A; Bertolli V; Quirici N; Deliliers GL
Leukemia; 1991 Dec; 5(12):1026-30. PubMed ID: 1723130
[TBL] [Abstract][Full Text] [Related]
20. [LAT (linker for activation of T cells): a useful marker for megakaryocyte evaluation on bone marrow biopsies].
Ungari M; Pellegrini W; Borlenghi E; Marocolo D; Ubiali A; Agazzi C; Pich A; Franco V; Facchetti F
Pathologica; 2002 Dec; 94(6):325-30. PubMed ID: 12540999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
